Back to jobs

CRA

Job description

Contract Senior CRA โ€“ Oncology (12-Month Contract, UK Remote)
(Outside IR35) | ๐ŸŒ UK Remote | ๐Ÿงช Phase III Solid Tumor Trial

We are partnering with a fast-growing, innovative biotechnology company advancing cutting-edge immuno-oncology therapies. As they scale their pivotal Phase III Solid Tumor study, they are seeking an experienced Contract Clinical Research Associate (CRA) to join their UK team.

This is a fantastic opportunity to work on a high-profile, late-phase oncology trial with a sponsor who values collaboration, innovation, and clinical excellence.

The Role

  • Contract length: 12 months (with strong potential for extension)

  • Therapeutic area: Oncology โ€“ Solid Tumors (Phase III)

  • Coverage: 11 UK sites, supported by a team of 2 CRAs

  • Location: Remote (UK-based), with routine travel to sites

  • Engagement: Outside IR35

Responsibilities

  • Conduct routine on-site and remote monitoring (PSV, SIV, IMV, COV) across multiple UK sites.

  • Ensure full compliance with ICH-GCP, study protocol, and sponsor SOPs.

  • Maintain strong relationships with investigators and site staff to drive recruitment and data quality.

  • Oversee SDV/SDR, query resolution, and timely site documentation updates in eTMF.

  • Support audit/inspection readiness, corrective/preventive actions (CAPAs), and risk-based monitoring activities.

Requirements

  • 5+ years CRA experience, with a strong background in oncology trials (solid tumor preferred).

  • Proven expertise in Phase II/III oncology studies within the UK.

  • Ability to independently manage multiple sites and ensure timely study deliverables.

  • Strong working knowledge of EDC systems (Medidata Rave preferred), CTMS, and eTMF.

  • UK-based, with flexibility to travel across assigned sites.

Why Apply?

  • Join a sponsor-driven study rather than a CRO environment โ€“ your impact will be felt directly on trial outcomes.

  • Contribute to a pivotal Phase III oncology program that has the potential to change treatment landscapes.

  • Competitive outside IR35 contract rate with long-term engagement potential.